2019/09/23 | Flash News – Archimed expands neurodiagnostic business in Europe and the US

ArchiMed, European private equity healthcare specialist, announces successful growth of its portfolio company Micromed into Neurodiagnostics – on both sides of the Atlantic. Archimed expands neurodiagnostic business in Europe and the US Portfolio Company, Micromed, a European-based neurodiagnostic system manufacturer has moved to direct sales in the United States and its wholly owned subsidiary, US based Moberg…

MORE

2018/06/09 | ArchiMed acquires majority stake in Soest Medical Group

Specialist healthcare investor ArchiMed has acquired a majority stake in Netherlands-based Soest Medical Group (SMG) which produces adhesives used during surgery. SMG has two brands: seller of reusable adhesives Eurotape and disposable adhesives provider Somed. Its revenues are growing at a rate of around 10 per cent annually, according to ArchiMed. With ArchiMed’s backing, SMG…

MORE

2018/06/08 | ArchiMed adds two as partners

France-based ArchiMed, a healthcare-focused private equity firm, have hired Benoît Adelus and André-Michel Ballester as partners. Adelus was the chairman and CEO of Sebia while Ballester is currently chairman of ArchiMed portfolio company Citieffe. PRESS RELEASE February 12, 2018 – Benoît Adelus and André-Michel Ballester are joining the senior management of European private equity healthcare…

MORE

2018/04/23 | Provepharm Life Solutions forms alliance with new strategic partners, ArchiMed and Téthys Invest

Marseille, April 23, 2018 – Provepharm Life Solutions announces today that ArchiMed and Téthys Invest have joined the company’s shareholder base as minority investors. Both are renowned investors with strong expertise in the healthcare sector. Beyond financial considerations, it was the specific support for the company’s long-term growth project and the entrepreneurial track record of its…

MORE